Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testing Pharmacological Therapies for Pregnant Smokers
NCT00224419Phase 4Terminated
- Sponsor
- Duke University
- Start
- Jun 2003
- Primary completion
- Aug 2006
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nicotine patch in nicotine dependence (2 arms), sponsored by Duke University. Primary endpoint: Biochemically-validated 7-day prevalent abstinence rate. Started Jun 2003; status: terminated.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00224419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224419.